Category:Timothy Weeden of Walthem MA (US)

Timothy Weeden of Walthem MA (US)

Executive Summary

Timothy Weeden of Walthem MA (US) is an inventor who has filed 1 patents. Their primary areas of innovation include PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms (1 patents), PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms (1 patents), PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms (1 patents), and they have worked with companies such as Dyne Therapeutics, Inc. (1 patents). Their most frequent collaborators include (1 collaborations), (1 collaborations), (1 collaborations).

Patent Filing Activity

Technology Areas

List of Technology Areas

• A61K47/6807 (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms): 1 patents
• A61K38/1709 (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms): 1 patents
• A61K47/6849 (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms): 1 patents
• A61K47/6889 (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms): 1 patents
• A61P25/00 (Drugs for disorders of the nervous system): 1 patents
• C07K16/2881 (PEPTIDES (peptides in foodstuffs): 1 patents
• C12N15/113 (Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; {Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing (when used in plants): 1 patents
• C12N2310/11 (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media): 1 patents
• C12N2310/315 (of the backbone): 1 patents
• C12N2310/321 (2'-O-R Modification): 1 patents
• C12N2310/3341 (of the base): 1 patents

Companies

List of Companies

• Dyne Therapeutics, Inc.: 1 patents

Collaborators

• Romesh R. Subramanian of Framingham MA (US) (1 collaborations)
• Cody A. Desjardins of Waltham MA (US) (1 collaborations)
• Oxana Beskrovnaya of Waltham MA (US) (1 collaborations)
• Mohammed T. Qatanani of Waltham MA (US) (1 collaborations)
• Brendan Quinn of Boston MA (US) (1 collaborations)
• John Najim of Waltham MA (US) (1 collaborations)
• Victor Kotelianski of Newton MA (US) (1 collaborations)
• Duncan Brown of Berkeley CA (US) (1 collaborations)